AlphaYouTK
Insider buying
Thomas K Equels bought $2K of AIM ImmunoTech Inc. (AIM) stock
Thomas K Equels, CEO & President of AIM ImmunoTech Inc. (AIM), bought 11,000 shares of AIM stock worth $2K, per an SEC Form 4 filed Sep 17, 2026.
It was an open-market purchase.
The trade happened on Sep 16, 2026, 1 day before it was made public.
AIM has moved -1.2% since the trade date, from $0.21 to $0.21 (Sep 21, 2026 close).
- Traded
- Sep 16, 2026
- Disclosed
- Sep 17, 2026
- Filing delay
- 1 day
- Price since
- -1.2%
- Role
- CEO & President
- Source
- SEC Form 4
More AIM insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.